Friedreich Ataxia Global Clinical Consortium UNIFIED Natural History Study
Friedreich's Ataxia Research Alliance · NCT06016946
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Any age listed · All sexes
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 3000
- US sites recruiting
- 9
- Study start
- June 28, 2023
- Record last updated
- September 1, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
This project is a global, multicenter, prospective, longitudinal, observational natural history study that can be used to understand the disease progression and support the development of safe and effective drugs and biological products for Friedreich ataxia.
Conditions: Friedreich Ataxia
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Both males and females of any age
- Individuals with Friedreich ataxia (FA): Participants that meet genetically confirmed diagnosis of Friedreich ataxia
- Written informed consent provided
- Informed consent must be obtained for all participants
- For underage participants, they and the parent/ legally authorized representative have to sign the informed consent form, child assent (if applicable)
- Persons who are not legally competent require the informed consent of their legally authorized representative
Exclusion Criteria
- Unable or unwilling to provide informed consent
- Acute or ongoing medical or other conditions that would interfere with the conduct and assessments of the study
- For any reason in the opinion of the investigator, participant would be unlikely or unable to comply with study protocol requirements.
Recruiting US locations
UCLA Ataxia Center
Los Angeles, CA 90095
Site contact: Westley Ulit · 1-310-206-8153 · WUlit@mednet.ucla.edu
University of Colorado
Denver, CO 80045
Site contact: Dillan Patel · 303-724-2642 · DILLAN.PATEL@CUANSCHUTZ.EDU
University of Florida - Neurology
Gainesville, FL 32610
Site contact: Mackenzi Coker · 1-352-294-8754 · mcoker@peds.ufl.edu
USF Ataxia Research Center
Tampa, FL 33612
Site contact: FA Study · 1-813-974-5909 · lcampbel@usf.edu
Emory University Hospital - Neurology
Atlanta, GA 30329
Site contact: UNIFAI Study · 404-727-1509
University of Iowa, Stead Family Children's Hospital
Iowa City, IA 52242
Site contact: Corey McDaniel · 1-319-335-7498 · corey-mcdaniel@uiowa.edu
Ohio State University - Neurology
Columbus, OH 43221
Site contact: Marco Tellez · 614-688-7837 · marco.tellez@osumc.edu
Children's Hospital of Philadelphia
Philadelphia, PA 19104
Site contact: FA Program · 267-426-7538 · FAPROGRAM@chop.edu
St. Jude Children's Research Hospital
Memphis, TN 38105
Site contact: Jean Laboe · 1-901-595-1693 · jean.laboe@stjude.org
Study contacts (from the official record)
- Mackenzi Coker · +14848796160 · fagcc-clinops@curefa.org
- Jennifer Farmer · 14848796160 · jen.farmer@cureFA.org
Similar studies in California
All healthy volunteers studies in California →- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Study to Investigate the Relative Bioavailability and Safety of Different Oral Formulations of Elecoglipron in Healthy Participants
AstraZeneca
- Location
- Glendale, CA + 1 other US site
- Eligibility basics
- Ages 18–55
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Phase I Study to Investigate the Pharmacokinetics and Safety of Capivasertib in Participants With Moderate Hepatic Impairment
AstraZeneca
- Location
- Rialto, CA + 1 other US site
- Eligibility basics
- Ages 18–80
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Study to Learn How the Body Processes the Study Medicine PF-07328948 in People With Reduced Kidney Function
Pfizer
- Location
- Lake Forest, CA + 3 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
Phase 1 Study of SBS-147 in Healthy Adults
Sparian Biosciences, Inc
- Location
- Cypress, CA
- Eligibility basics
- Ages 18–55